MHRA Seeks Feedback on Draft Guidance for Personalised mRNA Cancer Immunotherapies
MHRA Seeks Feedback on Draft Guidance for Personalised Cancer Therapies The Medicines and Healthcare products Regulatory Agency (MHRA) has launched an eight-week consultation on its draft guidance for individualised mRNA cancer immunotherapies. The agency’s Chief Executive believes this guidance will address the unique challenges posed by these personalised cancer treatments. The MHRA aims to improve … Read more